These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Therapeutic control of complement activation at the level of the central component C3. Ricklin D; Lambris JD Immunobiology; 2016 Jun; 221(6):740-6. PubMed ID: 26101137 [TBL] [Abstract][Full Text] [Related]
3. The renaissance of complement therapeutics. Ricklin D; Mastellos DC; Reis ES; Lambris JD Nat Rev Nephrol; 2018 Jan; 14(1):26-47. PubMed ID: 29199277 [TBL] [Abstract][Full Text] [Related]
4. From orphan drugs to adopted therapies: Advancing C3-targeted intervention to the clinical stage. Mastellos DC; Reis ES; Yancopoulou D; Hajishengallis G; Ricklin D; Lambris JD Immunobiology; 2016 Oct; 221(10):1046-57. PubMed ID: 27353192 [TBL] [Abstract][Full Text] [Related]
5. Manipulating the mediator: modulation of the alternative complement pathway C3 convertase in health, disease and therapy. Ricklin D Immunobiology; 2012 Nov; 217(11):1057-66. PubMed ID: 22964231 [TBL] [Abstract][Full Text] [Related]
6. Tipping the balance: intricate roles of the complement system in disease and therapy. Pouw RB; Ricklin D Semin Immunopathol; 2021 Dec; 43(6):757-771. PubMed ID: 34698894 [TBL] [Abstract][Full Text] [Related]
10. Complement in clinical medicine: Clinical trials, case reports and therapy monitoring. Ricklin D; Barratt-Due A; Mollnes TE Mol Immunol; 2017 Sep; 89():10-21. PubMed ID: 28576323 [TBL] [Abstract][Full Text] [Related]
11. Complement, a target for therapy in inflammatory and degenerative diseases. Morgan BP; Harris CL Nat Rev Drug Discov; 2015 Dec; 14(12):857-77. PubMed ID: 26493766 [TBL] [Abstract][Full Text] [Related]
16. Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads. Tatapudi VS; Montgomery RA Front Immunol; 2019; 10():2306. PubMed ID: 31632397 [TBL] [Abstract][Full Text] [Related]
17. Editorial: Therapeutic Modulation of the Complement System: Clinical Indications and Emerging Drug Leads. Mastellos DC; Reis ES; Lambris JD Front Immunol; 2019; 10():3029. PubMed ID: 31998311 [No Abstract] [Full Text] [Related]
18. Developments in anti-complement therapy; from disease to clinical trial. Harris CL; Pouw RB; Kavanagh D; Sun R; Ricklin D Mol Immunol; 2018 Oct; 102():89-119. PubMed ID: 30121124 [TBL] [Abstract][Full Text] [Related]